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Abstract  Colonoscopy  is  one  of  the  most  common  procedures.  Sedation  and  analgesia  decrease
anxiety and  discomfort  and  minimize  risks.  Therefore,  patients  prefer  to  be  sedated  when
undergoing  examination,  although  the  best  combination  of  drugs  has  not  been  determined.  The
combination  of  opioids  and  benzodiazepines  is  used  to  relieve  the  patient’s  pain  and  discomfort.
More recently,  propofol  has  assumed  a  prominent  position.  This  randomized  prospective  study
is unique  in  medical  literature  that  speciﬁcally  compared  the  use  of  propofol  and  fentanyl  with
or without  midazolam  for  colonoscopy  sedation  performed  by  anesthesiologists.  The  aim  of  this
study was  to  evaluate  the  side  effects  of  sedation,  discharge  conditions,  quality  of  sedation,
and propofol  consumption  during  colonoscopy,  with  or  without  midazolam  as  preanesthetic.
The study  involved  140  patients  who  underwent  colonoscopy  at  the  University  Hospital  of  the
Federal University  of  Juiz  de  Fora.  Patients  were  divided  into  two  groups:  Group  I  received  intra-
venous midazolam  as  preanesthetic  5  min  before  sedation,  followed  by  fentanyl  and  propofol;
Group II  received  intravenous  anesthesia  with  fentanyl  and  propofol.  Patients  in  Group  II  had  a
higher incidence  of  reaction  (motor  or  verbal)  to  the  colonoscope  introduction,  bradycardia,
hypotension,  and  increased  propofol  consumption.  Patient  satisfaction  was  higher  in  Group  I.
According  to  the  methodology  used,  the  combination  of  midazolam,  fentanyl,  and  propofol  for
colonoscopy  sedation  reduces  propofol  consumption  and  provides  greater  patient  satisfaction.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights© 2015  Sociedade  Brasileir
reserved.∗ Corresponding author.
E-mail: lincoln.ferreira@ufjf.edu.br (L.E.V.V.C. Ferreira).
http://dx.doi.org/10.1016/j.bjane.2014.09.014
0104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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Sedac¸ão para  colonoscopia:  ensaio  clínico  comparando  propofol  e  fentanil  associado
ou  não  ao  midazolam
Resumo  A  colonoscopia  é  um  dos  procedimentos  mais  feitos.  Sedac¸ão  e  analgesia  diminuem
a ansiedade  e  o  desconforto  e  minimizam  riscos.  Em  razão  disso,  os  pacientes  preferem  que
o exame  seja  feito  sob  anestesia,  embora  não  tenha  sido  determinada  a  melhor  combinac¸ão
de fármacos.  A  associac¸ão  de  benzodiazepínicos  com  opioides  é  usada  para  aliviar  a  dor  e  o
desconforto  do  paciente.  Mais  recentemente,  o  propofol  assumiu  posic¸ão  de  destaque.  Este
estudo, prospectivo  e  randomizado,  é  único  na  literatura  médica  e  especiﬁcamente  comparou
o uso  do  propofol  e  fentanil  associado  ou  não  ao  midazolam  na  sedac¸ão  para  colonoscopia  feita
por anestesiologistas.  Os  objetivos  do  estudo  foram  avaliar  os  efeitos  colaterais  da  sedac¸ão,  as
condic¸ões de  alta,  a  qualidade  da  sedac¸ão  e  o  consumo  de  propofol  durante  a  colonoscopia,  com
ou sem  o  midazolam  como  pré-anestésico.  Envolveu  140  pacientes  submetidos  à  colonoscopia,
no Hospital  Universitário  da  Universidade  Federal  de  Juiz  de  Fora.  Os  pacientes  foram  dividi-
dos em  dois  grupos.  O  Grupo  I recebeu,  por  via  endovenosa,  midazolam  como  pré-anestésico,
cinco minutos  antes  da  sedac¸ão,  seguido  do  fentanil  e  propofol.  O  Grupo  II  recebeu,  por  via
endovenosa,  anestesia  com  fentanil  e  propofol.  Os  pacientes  do  Grupo  II  apresentaram  maior
incidência de  reac¸ão  (motora  ou  verbal)  à  introduc¸ão  do  colonoscópio,  bradicardia,  hipotensão
arterial  e  maior  consumo  de  propofol.  A  satisfac¸ão  dos  pacientes  foi  maior  no  Grupo  I.  De  acordo
com a  metodologia  empregada,  a  associac¸ão  de  midazolam  ao  propofol  e  fentanil  para  sedac¸ão
em colonoscopia  reduz  o  consumo  de  propofol  e  cursa  com  maior  satisfac¸ão  do  paciente.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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olonoscopy  is  one  of  the  most  common  procedures  in  the
orld.  Sedation  and  analgesia  are  considered  key  compo-
ents,  as  they  reduce  anxiety  and  discomfort  and  therefore
mprove  the  procedure  tolerability  and  patient  satisfaction,
inimize  risk  of  complications  and  provide  better  condi-
ions  for  the  examination.1,2 Colonoscopy  pain  results  from
esenteric  traction  maneuvers  and  colonic  distension  by  gas
nsufﬂation  and  the  device  frequent  winding  inside  the  intes-
ine,  which  requires  correction  maneuvers.3--6 As  a result,
any  patients  prefer  the  examination  done  under  sedation
nd  analgesia.7
Although  the  goal  of  sedation  is  to  facilitate  colonoscopy,
atients  may  have  varying  degrees  of  impairment  in  their
ognitive  function,  with  a  consequent  delay  in  discharge
nd  restrictions  in  various  daily  activities.  The  combination
f  benzodiazepines  with  opioids  has  been  used  since  1980
n  colonoscopy  procedures  to  alleviate  patient’s  pain  and
iscomfort.  More  recently,  propofol  has  taken  a  prominent
osition.4--7
Propofol  may  be  used  alone  or  in  combination  with
pioids  (fentanyl  25--75  g,  meperidine  25--50  mg),  and/or
enzodiazepines  (midazolam  0.5--2.5  mg),  but  there  is  no
lear  evidence  that  the  combination  of  propofol  with  other
rugs  leads  to  reduction  of  side  effects.8 The  use  of  propo-
ol  alone  requires  higher  doses,  which  may  lead  to  increased
ncidence  of  side  effects.  However,  the  risks  and  beneﬁts
f  adding  analgesic  and  sedative  to  propofol  are  contro-
ersial,  and  the  selection  of  drugs  is  a  crucial  factor  in
etermining  the  outcomes.9 Regardless  of  the  drug  used,  the
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wnesthesia  for  colonoscopy  is  related  to  complications  such
s  hypoxia,  respiratory  depression,  apnea,  hypotension,  and
ardiac  dysrhythmia.6,7,10,11
Based  on  surveys,  only  two  studies  evaluated  the  use
f  propofol  and  fentanyl  combined  with  midazolam  for
olonoscopy.  However,  both  studies  used  propofol  alone  as
he  basis  for  comparison  with  the  other  three  groups:  fen-
anyl  and  propofol,  midazolam  and  propofol,  and  propofol
ith  fentanyl  and  midazolam.9,12 In  the  study  by  Pad-
anabhan  et  al.,  although  sedation  has  been  made  by
nesthesiologists,  the  objective  of  the  studies  was  to  eval-
ate  only  the  cognitive  function  of  patients  post-sedation,
ithout  any  mention  of  the  parameters  related  to  the  endo-
copic  procedure.9 In  turn,  in  the  survey  conducted  by  Rex
nd  Vannatta,  although  variables  similar  to  ours  have  been
valuated,  the  sedation  was  made  by  registered  nurses  and
upervised  by  endoscopists.
Our  study  is  unique  in  the  literature  that  speciﬁcally
ompared,  prospectively,  the  use  of  propofol  and  fen-
anyl  associated  or  not  with  midazolam  in  sedation  for
olonoscopy  performed  by  anesthesiologists.
ethods
 prospective,  randomized,  double-blind  study,  involving
40  patients  undergoing  colonoscopy  at  the  University  Hos-
ital  (HU/CAS)  of  the  Federal  University  of  Juiz  de  Fora
UFJF),  from  December  2010  to  December  2011.  The  study
as  approved  by  the  Research  Ethics  Committee.
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The  study  included  men  and  women,  aged  between  18
and  60  years,  ASA  I-II,  referred  to  the  Digestive  Endoscopy
Unit  of  HU/CAS  of  UFJF  for  a  diagnostic  colonoscopy.
Patients  invited  to  participate  in  the  study  signed  the
informed  consent,  and  the  study  primary  objectives  were
to  evaluate  the  side  effects  of  sedation,  discharge  condi-
tions  from  the  post-anesthesia  care  unit  (PACU),  and  quality
of  sedation  in  the  opinion  of  the  endoscopist  and  patient.
Secondarily,  we  evaluated  the  total  consumption  of  propo-
fol.
The  exclusion  criteria  were  patients  with  chronic  use  of
drugs  such  as  benzodiazepines,  neuroleptics,  and  anticon-
vulsants  for  more  than  30  days;  hypersensitivity  reactions
to  drugs  used  in  the  study;  those  undergoing  abdominal
laparotomy;  body  mass  index  above  35  kg  m−2;  psychiatric
patients;  inadequate  preparation  conditions,  deﬁned  as
those  preventing  or  hindering  the  examination;  patients
with  clinical  suspicion  of  intestinal  subocclusion  or  stenotic
colon  tumors;  using  drugs  that  interfere  with  the  heart
rate;  requiring  complex  therapeutic  procedures  set  dur-
ing  diagnostic  colonoscopy,  such  as  polypectomy  of  larger
polyps,  ﬂat  lesion  mucosectomy,  and  multiple  polypectomy
(>3).
In  total,  140  patients  were  allocated  randomly  into  two
groups.  A  third  doctor,  responsible  for  randomization,  pre-
pared  the  syringe  with  premedication  (midazolam)  and
placebo  (distilled  water),  so  that  both  the  endoscopist  and
the  anesthesiologist  in  charge  of  sedation  were  blind  to  the
allocation  of  patients.
All  patients  were  monitored  with  pulse  oximetry,  contin-
uous  ECG,  and  noninvasive  blood  pressure  assessed  every
5  min.  The  groups  consisted  of  70  patients  each  (Group  I
and  Group  II).  In  Group  I,  patients  received  intravenous  (IV)
midazolam  (0.05  mg  kg−1)  as  a  pre-anesthetic  5 min  before
sedation,  followed  by  IV  fentanyl  (1  g  kg−1)  and  propofol
(1  mg  kg−1).
In  Group  II,  patients  received  anesthesia  with  IV  fentanyl
(1  g  kg−1)  and  propofol  (1  mg  kg−1).  In  both  groups,  anes-
thesia  was  induced  with  propofol,  and  the  total  loading  dose
was  applied  slowly,  within  60  s,  or  limited  to  the  drooping
eyelid  with  loss  of  corneal-palpebral  reﬂex.  The  mainte-
nance  dose  of  0.5  mg  kg−1,  was  repeated  whenever  there
were  signs  of  discomfort  (motor  or  verbal  reaction,  tachy-
cardia  and/or  hypertension).  In  both  groups,  supplementary
oxygen  was  offered  with  nasal  catheter  (3  L  min−1).
Endoscopic  examination  was  performed  by  two  experi-
enced  endoscopists  using  a  Fujinon  4400  video  system  and
colonoscopy  tubes  of  the  series  490.
During  procedures,  age,  weight,  and  height  of  patients;
indication  for  colonoscopy;  reactions  (motor  or  verbal)
to  the  introduction  of  the  colonoscope;  time  to  colono-
scope  introduction  into  the  cecum;  total  examination  time;
dose  of  propofol  induction;  total  propofol  consumption;
cardiovascular  disorders:  hypertension  and  tachycardia,
deﬁned  as  elevated  blood  pressure  and  heart  rate  levels
greater  than  20%  above  preanesthetic  values;  hypoten-
sion  and  bradycardia,  deﬁned  as  a  loss  greater  than  20%
above  preanesthetic  values,  and  changes  in  the  levels  of
peripheral  hemoglobin  oxygen  saturation.  In  cases  where
hypoxia  lasted  for  more  than  30  s or  the  drop  reached
levels  below  80%,  ventilation  was  started  with  a  face
mask.
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After  30  minutes  in  the  PACU,  the  patients  with  a  score
9  according  to  the  Aldrete--Kroulik  modiﬁed  index  were
onsidered  ﬁt  for  discharge.13 Finally,  we  evaluated  the  sat-
sfaction  of  the  endoscopist  and  patient  using  a visual  analog
cale  (0  =  dissatisﬁed  and  10  =  extremely  satisﬁed).
Statistical  analysis  was  performed  and  initially  we  evalu-
ted  the  data  normality  using  the  Kolmogorov-Sminorv  test.
hen  we  chose  to  use  non-parametric  tests  because  the  data
id  not  reach  normal  distribution.  To  compare  the  means  of
he  two  groups,  we  used  the  Mann--Whitney  test,  and  to
ompare  proportions  we  used  the  chi-square  test.  All  ana-
yzes  were  performed  using  the  Graph  Pad  Prism  version  5.01
oftware,  and  a  p-value  <0.05  was  considered  statistically
igniﬁcant.
esults
able  1  shows  a  summary  of  all  the  research  data,  includ-
ng  general  data  related  to  colonoscopy,  cardiovascular  and
emoglobin  saturation  changes,  sedation,  and  anesthetic
ecovery.
All patients  underwent  a  complete  colonoscopy  examina-
ion.  Regarding  the  examination,  patients  in  Group  II  had  a
igher  incidence  of  reaction  (motor  or  verbal)  to  the  colono-
cope  introduction  (p  <  0.04).
Regarding  cardiovascular  changes,  Group  II  had  a  higher
requency  of  hypotension,  although  this  difference  did  not
each  statistical  signiﬁcance  (p  =  0.121),  and  a  greater  num-
er  of  episodes  of  bradycardia  (p  =  0.04).  Only  one  episode
f  mild  hypoxemia  was  seen  in  each  group.
The  mean  dose  of  propofol  used  for  induction  was  similar
etween  both  groups.  However,  the  total  consumption  of
ropofol  was  higher  in  Group  II,  and  this  difference  reached
tatistical  signiﬁcance  (p  <  0.001).
The  assessment  of  patients  in  the  PACU  with  the  use  of
ldrete--Kroulik  modiﬁed  scale  and  the  satisfaction  of  endo-
copists  and  patients  are  shown  at  the  end  of  Table  1.  When
omparing  these  three  variables,  only  pacient  satisfaction
as  signiﬁcantly  higher  in  Group  I  (p  =  0.006).
iscussion
olonoscopy  is  a  procedure  often  performed  for  preven-
ion,  diagnosis,  and  treatment  of  a  variety  of  symptoms
nd  diseases  of  the  lower  digestive  tract,9,14 and  sedation
r  anesthesia  should  be  considered  as  an  important  tool  to
ncrease  its  effectiveness.15
Sedation  or  anesthesia  is  intended  to  decrease  anxiety
nd  discomfort,  increase  tolerance  and  satisfaction  with  the
rocedure,  reduce  risks  of  complications,  and  promote  sat-
sfactory  conditions  for  the  examination.2,5,15
The  dose  and  the  depth  of  sedation  should  be  indi-
idualized  according  to  the  needs  of  each  patient.2
astrointestinal  endoscopic  procedures  are  often  complex
nd  require  endoscopist’s  attention.  Patient  cooperation
nd  anesthesiologist  participation  help  to  improve  the
rocedure,2,16,17 increase  the  detection  of  polyps,  and  facil-
tate  therapeutic  procedures.7,16
There  are  several  anesthetic  techniques  available  for
olonoscopy.2 Traditionally,  the  combination  of  narcotics
nd  benzodiazepines  has  been  used  and,  more  recently,
234  J.F.N.P.  Neves  et  al.
Table  1  Study  data.
Group  I  Group  II  p
n  70  70  --
Sex (male/female)  35.7/64.3  38.5/61.4  --
Mean age  (years)  48.4  ±  9.7  48  ±  10.8  0.996
Weight (kg)  71.1  ±  13.2  69.8  ±  13.2  0.670
Height (m)  1.7  ±  0.1  1.7  ±  0.1  0.849
Colonoscopy  data
RCI  3/70  (4.3%)  14/70  (20%)  <0.04
MTIC 6.9  ±  3.5  6.3  ±  3.0  0.590
TET 19.4  ±  6.4  20.2  ±  5.6  0.191
Cardiovascular  and  SpO2 data
Arterial  hypertension  1/70  (1.4%)  0/70  (0%)  0.315
Arterial hypotension  14/70  (20%)  22/70  (31%)  0.121
Tachycardia 0/70  (0%)  0/70  (0%)  1.000
Bradycardia  0/70  (0%)  4/70  (5.6%)  0.04
SpO2 1/70  (1.4%)  1/70  (1.4%)  1.000
Sedation data
MDI  (mg) 70.6  ±  13.4 71  ±  14.6  0.890
TCP (mg) 153  ±  60.3 206  ±  79.2 <0.001
Anesthetic recovery  data
AKI  >  9  70/70  (100%)  70/70  (100%)  >0.05
ESR 9.7  ±  0.7  9.6  ±  0.7  0.432
PSR 9.8  ±  0.5  9.4  ±  1.0  0.006
Sex, data expressed as a percentage; age, weight and height: data expressed as mean and standard deviation; RCI, reaction to colonoscope
introduction; n, no of cases/no of patients (%); MTIC, mean time of device introduction to the cecum in minutes; TET, total examination
time (mean in minutes); MDI, mean dose of propofol induction; TCP, total consumption of propofol; AKI, post-anesthetic recovery
according to the modiﬁed Aldrete--Kroulik index; ESR, endoscopist satisfaction ratings (mean and standard deviation); PSR, patient
satisfaction ratings (mean and standard deviation).
p
m
c
h
p
p
d
T
p
i
m
t
p
p
v
s
a
b
e
f
w
a
t
m
m
t
t
d
p
i
r
s
g
c
T
r
u
t
t
dropofol  occupies  a  prominent  place.1,2,7,16--18 The  phar-
acokinetic  model  of  propofol  presents  a  safe  agent  for
olonoscopy  because  it  has  an  amnesic  effect  and  a  4-min
alf-life,  which  provides  fast  recovery  and  awake  even  after
rolonged  administration.19 However,  the  analgesic  effect  of
ropofol  is  limited  and,  when  used  as  a  single  agent,  higher
oses  are  required  which  increases  the  risk  of  deep  sedation.
he  bolus  administration  associated  with  a  short  half-life  of
ropofol  facilitates  the  occurrence  of  ‘‘sedation  waves’’,
n  which  deep  sedation  peaks  and  respiratory  depression
ay  alternate  with  episodes  of  superﬁciality  and  risk  of  agi-
ation  during  colonoscopy.9 The  use  of  continuous  infusion
ump  minimizes  this  problem,  but  increases  the  cost  of  the
rocedure.
It  also  should  be  considering  that,  because  propofol  has  a
ery  narrow  therapeutic  window,  which  leads  easily  from  a
tate  of  moderate  to  deep  sedation  or  general  anesthesia,2
nd  because  there  is  no  reversal  agent,  propofol  should  only
e  administered  by  an  anesthesiologist  or  doctor  with  proven
xperience  in  airway  management.9
To  reduce  these  mentioned  risks,  sedation  with  propo-
ol  in  colonoscopy  has  its  administration  often  associated
ith  fentanyl  and/or  midazolam,  which,  in  small  doses,  usu-
lly  produce  moderate  sedation.4,16,18 Some  studies  reported
c
s
rhat  patients  receiving  combined  sedation  were  discharged
ore  quickly  and  reported  greater  satisfaction.4,20,21
Our  results  showed  that  patients  who  did  not  receive
idazolam  (Group  II)  had  a  higher  frequency  of  reaction
o  the  colonoscope  introduction  (Table  1).  We  believe  that
he  addition  of  midazolam  to  propofol  and  fentanyl,  at  the
oses  used  in  the  research  (minimum  recommended  doses),
rovides  a more  adequate  level  of  sedation  to  the  device
ntroduction.
The  similarity  between  the  two  groups  regarding  the
ectum-cecum  time  and  the  total  examination  time  (Table  1)
hows  that  procedures  were  technically  similar  in  both
roups,  and  thus  comparable.
Another  important  ﬁnding  in  our  study  was  the  total
onsumption  of  propofol  signiﬁcantly  lower  in  Group  I.
his  ﬁnding  is  consistent  with  the  literature,  in  which  the
educed  propofol  dose  is  associated  with  the  combined
se  of  opioids  and  benzodiazepines.4,6,9,21 The  combina-
ion  of  propofol  and  fentanyl  and/or  midazolam  reduces
he  consumption  of  propofol  and  decreases  the  risk  of
eep  sedation,  without  prolonging  the  recovery.22 A smaller
onsumption  of  propofol  is  usually  expected  in  combined
edation.12,16 Similarly  to  our  study,  two  other  studies
eported  lower  consumption  of  propofol  in  combination  with
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midazolam  and  fentanyl.12,16 Reduction  in  propofol  con-
sumption  is  an  important  technical  aspect  because  the  drug
has  no  speciﬁc  antidotes  or  antagonists,  which  can  be  con-
sidered  a  limiting  factor  for  its  use.14,19
Sedation  can  prolong  recovery  and  discharge  time  and
increase  costs  and  the  possibility  of  cardiopulmonary
complications.  Heart  rate,  blood  pressure,  and  pulse  oxime-
try  should  be  routinely  monitored,  and  some  protocols
suggest  supplemental  oxygen  administration,8 because  the
practice  of  sedation  for  colonoscopy  exposes  patients  to
increased  mortality  and  morbidity.  In  our  study,  we  found
a  higher  frequency  of  hypotension  in  Group  II  (Table  1).
Although  this  difference  did  not  reach  statistical  signif-
icance,  the  higher  frequency  of  hypotension  in  Group  II
patients  is  likely  due  to  the  increased  consumption  of  propo-
fol  in  this  group,  a  known  hypotensive  agent.  Also  in  Group
II,  we  noticed  an  increased  frequency  of  bradycardia,  which
may  be  explained  by  the  possibility  of  myocardial  depres-
sion.  The  interaction  of  propofol  with  muscarinic  cholinergic
receptors  is  concentration-dependent  and  may  induce
bradycardia.23
Regarding  the  peripheral  hemoglobin  oxygen  saturation,
we  observed  in  both  groups  only  one  patient  with  temporary
reduction  of  SpO2,  without  requirement  for  ventilation  with
a  face  mask.  Our  data  support  the  fact  that  both  techniques
are  safe  and  have  small  risk  of  cardiopulmonary  adverse
events,  as  reported  in  the  literature.12,16
The  possibility  of  early  discharge  from  PACU  is  an  impor-
tant  aspect  in  the  care  of  outpatients,  and  it  generates
improved  service  and  lower  costs.1 Although  our  study  does
not  focus  on  PACU  discharge  time,  our  results  showed  that
regardless  of  the  sedation  technique  used,  all  140  patients
were  discharged  with  an  Aldrete--Kroulik  modiﬁed  index  >9
after  30  min.
The  endoscopist  assessment  showed  no  difference
between  the  groups,  demonstrating  that  anesthesia,
regardless  of  the  combination  of  drugs  used,  facilitates
colonoscopy.  Patients  in  Group  II  had  a  higher  incidence
of  reaction  to  the  colonoscope  introduction,  which  may
be  related  to  the  decreased  satisfaction  with  the  tech-
nique  and  conﬁrms  that  the  addition  of  midazolam  improves
comfort.
Conclusion
According  to  the  methodology  used,  the  combination
of  midazolam,  propofol,  and  fentanyl  for  sedation  in
colonoscopy  reduces  the  total  consumption  of  propofol  and
is  associated  with  greater  patient  satisfaction.
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